Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists

Stroke Vasc Neurol. 2020 Jun;5(2):146-151. doi: 10.1136/svn-2020-000382. Epub 2020 Apr 1.

Abstract

Coronavirus disease 2019 (COVID-19) has become a pandemic disease globally. Although COVID-19 directly invades lungs, it also involves the nervous system. Therefore, patients with nervous system involvement as the presenting symptoms in the early stage of infection may easily be misdiagnosed and their treatment delayed. They become silent contagious sources or 'virus spreaders'. In order to help neurologists to better understand the occurrence, development and prognosis, we have developed this consensus of prevention and management of COVID-19. It can also assist other healthcare providers to be familiar with and recognise COVID-19 in their evaluation of patients in the clinic and hospital environment.

Keywords: brain; infection; stroke.

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Betacoronavirus / pathogenicity*
  • COVID-19
  • COVID-19 Testing
  • Central Nervous System / physiopathology
  • Central Nervous System / virology*
  • Central Nervous System Infections / diagnosis
  • Central Nervous System Infections / physiopathology
  • Central Nervous System Infections / therapy*
  • Central Nervous System Infections / virology
  • Clinical Laboratory Techniques / standards*
  • Consensus
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / physiopathology
  • Coronavirus Infections / therapy*
  • Coronavirus Infections / virology
  • Early Diagnosis
  • Host-Pathogen Interactions
  • Humans
  • Neurologists / standards*
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / physiopathology
  • Pneumonia, Viral / therapy*
  • Pneumonia, Viral / virology
  • Predictive Value of Tests
  • Prognosis
  • SARS-CoV-2